The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome
Erin E. Longbrake, Le H. Hua, Ellen M. Mowry, Susan A. Gauthier, Enrique Álvarez, Anne H. Cross, Jinglan Pei, Jessica Priest, Catarina Raposo, David A. Hafler, Ryan C. Winger
Topics & Concepts
OcrelizumabMedicineMultiple sclerosisClinical trialInternal medicinePlaceboPopulationRituximabOncologyPhysical therapyPathologyImmunologyLymphomaEnvironmental healthAlternative medicineMultiple Sclerosis Research StudiesImmunodeficiency and Autoimmune DisordersPeripheral Neuropathies and Disorders